Publicacións en colaboración con investigadores/as de KU Leuven (23)

2024

  1. Association between upper and lower respiratory disease among patients with primary ciliary dyskinesia: an international study

    ERJ Open Research, Vol. 10, Núm. 2

2023

  1. Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study

    Cardiovascular diabetology, Vol. 22, Núm. 1, pp. 82

  2. Characteristics of Otologic Disease Among Patients With Primary Ciliary Dyskinesia

    JAMA otolaryngology-- head & neck surgery, Vol. 149, Núm. 7, pp. 587-596

  3. Lack of Correlation of Sinonasal and Otologic Reported Symptoms With Objective Measurements Among Patients With Primary Ciliary Dyskinesia: An International Study

    Clinical and Experimental Otorhinolaryngology, Vol. 16, Núm. 4, pp. 407-412

  4. Sinonasal disease among patients with primary ciliary dyskinesia: An international study

    ERJ Open Research, Vol. 9, Núm. 3

2022

  1. Lipoprotein profiles of fat distribution and its association with insulin sensitivity

    Frontiers in Endocrinology, Vol. 13

2021

  1. Study protocol: The ear-nose-throat (ENT) prospective international cohort of patients with primary ciliary dyskinesia (EPIC-PCD)

    BMJ Open, Vol. 11, Núm. 10

2020

  1. Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

    Modern Pathology, Vol. 33, Núm. 5, pp. 792-801

2019

  1. A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project

    Lung Cancer, Vol. 131, pp. 95-103

  2. Diastolic left ventricular function in relation to circulating metabolic biomarkers in a population study

    European Journal of Preventive Cardiology, Vol. 26, Núm. 1, pp. 22-32

2018

  1. Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project

    Journal of Thoracic Oncology, Vol. 13, Núm. 3, pp. 413-425

2017

  1. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism

    Gut, Vol. 66, Núm. 4, pp. 620-632

  2. Peripheral blood mitochondrial DNA content in relation to circulating metabolites and inflammatory markers: A population study

    PLoS ONE, Vol. 12, Núm. 7

  3. Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project

    Lung Cancer, Vol. 111, pp. 143-149

2016

  1. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

    Nature Communications, Vol. 7

2015

  1. Diastolic left ventricular function in relation to circulating metabolic biomarkers in a general population

    Journal of the American Heart Association, Vol. 5, Núm. 3

2014

  1. Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project

    Journal of Clinical Oncology, Vol. 32, Núm. 25, pp. 2780-2787

2010

  1. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

    Clinical Cancer Research, Vol. 16, Núm. 17, pp. 4353-4362

  2. Triple-negative breast cancer: Present challenges and new perspectives

    Molecular Oncology, Vol. 4, Núm. 3, pp. 209-229

2009

  1. Combining HR-MAS and <i>In Vivo</i> MRI and MRSI Information for Robust Brain Tumor Recognition

    4TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND BIOLOGICAL ENGINEERING